`___________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., WATSON LABORATORIES, INC., DR. REDDY’S LABORATORIES,
`INC., DR. REDDY’S LABORATORIES, LTD., and SUN
`PHARMACEUTICALS INDUSTRIES LTD.
`Petitioner,
`v.
`MERCK SHARP & DOHME CORP.
`Patent Owner.
`_________________________
`Case IPR2020-00040
`U.S. Patent 7,326,708 B2
`___________________________
`MYLAN’S NOTICE OF DEPOSITION OF
`RUSSEL R. FERLITA
`
`US_145867560v1_391026-00257 9/21/2020 12:12 PM
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708 B2
`
`Pursuant to 37 C.F.R. § 42.53, prior agreement with counsel for Patent
`
`Owner Merck Sharp & Dohme Corp., and subject to further modification of the
`
`case schedule as authorized by the Board, Petitioner Mylan Pharmaceuticals Inc.,
`
`by and through its attorneys, will conduct the cross-examination by deposition of
`
`Russel R. Ferlita, on Thursday November 5, 2020. The deposition will be
`
`conducted by videoconference and will commence at 9:00 a.m., Eastern Time, or
`
`such time as the parties agree. The deposition shall be taken before a duly
`
`authorized notary public or other officer authorized to administer oaths and will be
`
`recorded by audiotape, videotape, and/or stenographic means.
`
`Date: September 21, 2020
`
`Respectfully submitted,
`
`/s Jitendra Malik/
`Jitendra Malik, Ph.D. (Reg. No. 55,823)
`Alissa M. Pacchioli (Reg. No. 74,252)
`Christopher W. West, Ph.D.
`(Reg. No. 74,724)
`Heike S. Radeke, Ph.D.
`(Reg. No. 75,394)
`Lance Soderstrom (Reg. No.65,405)
`KATTEN MUCHIN ROSENMAN
`550 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`jitty.malik@katten.com
`alissa.pacchioli@katten.com
`christopher.west@katten.com
`heike.radeke@katten.com
`lance.soderstrom@katten.com
`Counsel for Petitioner
`Mylan Pharmaceuticals Inc.
`
`US_145867560v1_391026-00257 9/21/2020 12:12 PM
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708 B2
`
`CERTIFICATION UNDER 37 C.F.R. § 42.24(d)
`
`Pursuant to 37 C.F.R. 42.6(e), the undersigned hereby certifies that a true
`
`and correct copy of the foregoing was served on September 21, 2020, by delivering
`
`a copy via electronic mail on the following attorneys of record.
`
`sfisher@wc.com
`
`jberniker@wc.com
`
`smahaffy@wc.com
`
`asheh@wc.com
`
`bgenderson@wc.com
`
`ebaumgarten@wc.com
`
`azolan@wc.com
`
`kzullow@goodwinprocter.com
`
`sfischer@goodwinprocter.com
`
`jwong@winston.com
`
`ZCohen@winston.com
`
`CKlein@winston.com
`
`Cfundakowski@winston.com
`
`rfaegenburg@lernerdavid.com
`
`tvanbuskirk@lernerdavid.com
`
`US_145867560v1_391026-00257 9/21/2020 12:12 PM
`
`
`
`Case IPR2020-00040 | U.S. Patent 7,326,708 B2
`
`mteschner@lernerdavid.com
`
`ERapalino@goodwinlaw.com
`
`/s Jitendra Malik/
`Jitendra Malik, Ph.D. (Reg. No. 55,823)
`
`US_145867560v1_391026-00257 9/21/2020 12:12 PM
`
`